%PDF-1.4
%öäüß
1 0 obj
<<
/Type /Catalog
/Pages 2 0 R
/Metadata 3 0 R
/Lang (en-GB)
/PageLabels 4 0 R
>>
endobj
5 0 obj
<<
/Title (Indeed Resume)
/Author (Indeed)
/Keywords (Indeed Resume)
/Creator (Indeed Resume)
/Producer (Apache FOP Version 1.0)
/CreationDate (D:20180104151130-06'00')
>>
endobj
2 0 obj
<<
/Type /Pages
/Count 2
/Kids [6 0 R 7 0 R]
>>
endobj
3 0 obj
<<
/Type /Metadata
/Subtype /XML
/Length 8 0 R
>>
stream
<?xpacket begin="ï»¿" id="W5M0MpCehiHzreSzNTczkc9d"?><x:xmpmeta xmlns:x="adobe:ns:meta/">
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<rdf:Description xmlns:pdf="http://ns.adobe.com/pdf/1.3/" rdf:about="">
<pdf:Keywords>Indeed Resume</pdf:Keywords>
<pdf:Producer>Apache FOP Version 1.0</pdf:Producer>
<pdf:PDFVersion>1.4</pdf:PDFVersion>
</rdf:Description>
<rdf:Description xmlns:dc="http://purl.org/dc/elements/1.1/" rdf:about="">
<dc:creator>Indeed</dc:creator>
<dc:title>Indeed Resume</dc:title>
<dc:subject>Indeed Resume</dc:subject>
<dc:date>2018-01-04T15:11:30-06:00</dc:date>
</rdf:Description>
<rdf:Description xmlns:xmp="http://ns.adobe.com/xap/1.0/" rdf:about="">
<xmp:CreatorTool>Indeed Resume</xmp:CreatorTool>
<xmp:MetadataDate>2018-01-04T15:11:30-06:00</xmp:MetadataDate>
<xmp:CreateDate>2018-01-04T15:11:30-06:00</xmp:CreateDate>
</rdf:Description>
</rdf:RDF>
</x:xmpmeta><?xpacket end="r"?>


endstream
endobj
4 0 obj
<<
/Nums [0 9 0 R 1 10 0 R]
>>
endobj
6 0 obj
<<
/Resources 11 0 R
/Type /Page
/MediaBox [0 0 612 792]
/CropBox [0 0 612 792]
/BleedBox [0 0 612 792]
/TrimBox [0 0 612 792]
/Parent 2 0 R
/Contents 12 0 R
>>
endobj
7 0 obj
<<
/Resources 11 0 R
/Type /Page
/MediaBox [0 0 612 792]
/CropBox [0 0 612 792]
/BleedBox [0 0 612 792]
/TrimBox [0 0 612 792]
/Parent 2 0 R
/Contents 13 0 R
>>
endobj
8 0 obj
930
endobj
9 0 obj
<<
/P (1)
>>
endobj
10 0 obj
<<
/P (2)
>>
endobj
11 0 obj
<<
/Font 14 0 R
/ProcSet [/PDF /ImageB /ImageC /Text]
/ColorSpace <<
/DefaultRGB [/ICCBased 15 0 R]
>>
>>
endobj
12 0 obj
<<
/Length 16 0 R
>>
stream
q
 1 0 0 -1 0 792 cm
 q
 1 0 0 1 90 72 cm
 0 g
 BT
 /F3 21 Tf
 1 0 0 -1 0 20.86599922 Tm
 [(Adriana England) ] TJ
 /F1 9 Tf
 1 0 0 -1 0 42.79899979 Tm
 [(Orlando, FL) ] TJ
 1 0 0 -1 47.52000046 42.79899979 Tm
 [( ) ] TJ
 1 0 0 -1 50.02199936 42.79899979 Tm
 [(32822) ] TJ
 1 0 0 -1 0 55.79899979 Tm
 [(adrianaengland8_ynn@indeedemail.com) ] TJ
 1 0 0 -1 163.70999 55.79899979 Tm
 [( - ) ] TJ
 1 0 0 -1 171.71098 55.79899979 Tm
 [(313-844-0877) ] TJ
 1 0 0 -1 0 80.7990036 Tm
 [(Seeking ) 8.7778 (a ) 8.7778 (challenging ) 8.7778 (career ) 8.7778 (within ) 8.7778 (the ) 8.7778 (Health ) 8.7778 (Care ) 8.7778 (Operations ) 8.7778 (Industry ) 8.7778 (to ) 8.7778 (obtain ) 8.7778 (a ) 8.7778 (position ) 8.7778 (of ) 8.7778 (responsibility,) ] TJ
 1 0 0 -1 0 93.7990036 Tm
 [(Using my skills) ] TJ
 1 0 0 -1 0 106.7990036 Tm
 [(efficiently ) -30.5556 (to ) -30.5556 (communicate ) -30.5556 (my ) -30.5556 (ideas ) -30.5556 (and ) -30.5556 (views ) -30.5556 (and ) -30.5556 (commit ) -30.5556 (myself ) -30.5556 (for ) -30.5556 (achieving ) -30.5556 (organization ) -30.5556 (objectives ) -30.5556 (with) ] TJ
 1 0 0 -1 0 119.7990036 Tm
 [(the team) ] TJ
 1 0 0 -1 0 132.79899597 Tm
 [(effort and my positive attitude and performance.) ] TJ
 1 0 0 -1 0 154.79899597 Tm
 [(Authorized to work in the US for any employer) ] TJ
 1 0 0 -1 0 185.79899597 Tm
 [(WORK EXPERIENCE) ] TJ
 /F3 10.5 Tf
 1 0 0 -1 0 209.68299866 Tm
 [(Insurance Verification Lead) ] TJ
 /F1 9 Tf
 1 0 0 -1 0 232.79899597 Tm
 [(PRIME THERAPEUTICS SPECIALTY PHARMACY) ] TJ
 1 0 0 -1 206.03700256 232.79899597 Tm
 [( ) ] TJ
 1 0 0 -1 213.53900146 232.79899597 Tm
 [(-) ] TJ
 1 0 0 -1 221.53599548 232.79899597 Tm
 [( ) ] TJ
 1 0 0 -1 224.03799438 232.79899597 Tm
 [(Orlando, FL) ] TJ
 1 0 0 -1 276.55801392 232.79899597 Tm
 [(-) ] TJ
 1 0 0 -1 0 254.79899597 Tm
 [(2012-10 - Present) ] TJ
 1 0 0 -1 0 276.79901123 Tm
 [<9550726F63657373696E6720> 64.6667 (of ) 64.6667 (Pharmacy ) 64.6667 (benefits ) 64.6667 (and ) 64.6667 (or ) 64.6667 (if ) 64.6667 (medication ) 64.6667 (is ) 64.6667 (required ) 64.6667 (to ) 64.6667 (be ) 64.6667 (covered ) 64.6667 (under ) 64.6667 (members ) 64.6667 (Major ) 64.6667 (Medical) ] TJ
 1 0 0 -1 0 289.79901123 Tm
 [(benefits.) ] TJ
 1 0 0 -1 0 302.79901123 Tm
 [(Authorization/PreCertification ) -271 (Initiation ) -271 (to ) -271 (plan ) -271 (with ) -271 (attached ) -271 (Clinicals. ) -271 (Follow ) -271 (up ) -271 (on ) -271 (Auth ) -271 (submissions.) ] TJ
 1 0 0 -1 0 315.79901123 Tm
 [(Verifying if provider is In-Network contracted with Member PPO, HMO, Idemnity Plans. ) ] TJ
 1 0 0 -1 0 328.79901123 Tm
 [<95446972656374206F6E20666C6F6F7220636F6E7461637420666F7220457363616C61746564206973737565732064656469636174656420746F204D495254205465616D2C20436C69656E7420526573706F6E7365205465616D73> ] TJ
 1 0 0 -1 0 341.79901123 Tm
 [<9520> -87.2222 (Skilled ) -87.2222 (on ) -87.2222 (the ) -87.2222 (Following ) -87.2222 (Referance ) -87.2222 (Catagories ) -87.2222 (Chronic ) -87.2222 (Illnesses ) -87.2222 (\(Hemophilia, ) -87.2222 (MS, ) -87.2222 (Rheumatoid ) -87.2222 (Arthritis,) ] TJ
 1 0 0 -1 0 354.79901123 Tm
 [(Fertility, ) -21.6667 (IVIG/ ) -21.6667 (Enzyme ) -21.6667 (Replacement, ) -21.6667 (Oncology ) -21.6667 (oral ) -21.6667 (& ) -21.6667 (injectable, ) -21.6667 (Growth ) -21.6667 (hormone, ) -21.6667 (Immune ) -21.6667 (Deficiency, ) -21.6667 (Hep) ] TJ
 1 0 0 -1 0 367.79901123 Tm
 [(C, Leukemia.) ] TJ
 1 0 0 -1 0 380.79901123 Tm
 [<955472696167696E6720> -145.5556 (Scripts ) -145.5556 (to ) -145.5556 (correct ) -145.5556 (participating/In- ) -145.5556 (Network ) -145.5556 (Pharmacies. ) -145.5556 (First ) -145.5556 (response ) -145.5556 (for ) -145.5556 (VIP ) -145.5556 (Physicians, ) -145.5556 (PCP) ] TJ
 1 0 0 -1 0 393.79901123 Tm
 [(Referral ) -90.1111 (initiations, ) -90.1111 (Provider ) -90.1111 (Services ) -90.1111 (in ) -90.1111 (which ) -90.1111 (multiple ) -90.1111 (referrals ) -90.1111 (are ) -90.1111 (scanned ) -90.1111 (for ) -90.1111 (this ) -90.1111 (referring ) -90.1111 (doctor. ) -90.1111 (Peer) ] TJ
 1 0 0 -1 0 406.79901123 Tm
 [(to ) -38.3333 (Peer ) -38.3333 (submissions ) -38.3333 (with ) -38.3333 (attached ) -38.3333 (Clinical ) -38.3333 (notes ) -38.3333 (and ) -38.3333 (documentation ) -38.3333 (for ) -38.3333 (UM ) -38.3333 (Nurse ) -38.3333 (Dept, ) -38.3333 (Coverage ) -38.3333 (Criteria,) ] TJ
 1 0 0 -1 0 419.79901123 Tm
 [(Quantity Limits, Overrides, DUR Rejections, Buy and Bill request.) ] TJ
 /F3 10.5 Tf
 1 0 0 -1 0 443.68301392 Tm
 [(NETWORK OPERATIONS REP) ] TJ
 /F1 9 Tf
 1 0 0 -1 0 466.79901123 Tm
 [(Blue Cross Blue Shield of Michigan) ] TJ
 1 0 0 -1 140.55299377 466.79901123 Tm
 [( ) ] TJ
 1 0 0 -1 148.05499268 466.79901123 Tm
 [(-) ] TJ
 1 0 0 -1 156.05200195 466.79901123 Tm
 [( ) ] TJ
 1 0 0 -1 158.55400085 466.79901123 Tm
 [(Detroit, MI) ] TJ
 1 0 0 -1 205.06199646 466.79901123 Tm
 [(-) ] TJ
 1 0 0 -1 0 488.79901123 Tm
 [(2009-07 - 2012-10) ] TJ
 1 0 0 -1 0 510.79901123 Tm
 [<9553657276656420> -53 (as ) -53 (primary ) -53 (point ) -53 (of ) -53 (contact ) -53 (to ) -53 (Network ) -53 (Pharmacies ) -53 (via ) -53 (the ) -53 (Network ) -53 (Management ) -53 (escalation ) -53 (phone) ] TJ
 1 0 0 -1 0 523.79901123 Tm
 [(line ) 10.7778 (and ) 10.7778 (collaborate ) 10.7778 (with ) 10.7778 (internal ) 10.7778 (stakeholders ) 10.7778 (to ) 10.7778 (resolve ) 10.7778 (inquiries ) 10.7778 (regarding ) 10.7778 (credentialing, ) 10.7778 (contracting, ) 10.7778 (claims) ] TJ
 1 0 0 -1 0 536.79901123 Tm
 [(payment, claims) ] TJ
 1 0 0 -1 0 549.79901123 Tm
 [(submission ) -315.3333 (requirements, ) -315.3333 (claim ) -315.3333 (reversals, ) -315.3333 (Drug ) -315.3333 (Pricing ) -315.3333 (Analysis ) -315.3333 (complaints, ) -315.3333 (and ) -315.3333 (other ) -315.3333 (miscellaneous) ] TJ
 1 0 0 -1 0 562.79901123 Tm
 [(reporting on a recurring basis as needed.) ] TJ
 1 0 0 -1 0 588.79901123 Tm
 [<954D6F6E69746F722C20> -219.3333 (respond ) -219.3333 (to, ) -219.3333 (and ) -219.3333 (escalate ) -219.3333 (inquiries ) -219.3333 (received ) -219.3333 (through ) -219.3333 (the ) -219.3333 (Network ) -219.3333 (Management ) -219.3333 (email ) -219.3333 (box ) -219.3333 (and) ] TJ
 1 0 0 -1 0 601.79901123 Tm
 [(Network. Management phone lines in a timely and professional manner. ) ] TJ
 ET
 Q
 Q
 
endstream
endobj
13 0 obj
<<
/Length 17 0 R
/Filter /FlateDecode
>>
stream
xœWYsÛ6~÷¯Àc2C+<ÄëQ‘”ˆ­®˜J;¶0	IhH‚@;ú÷YP$EL{<»‹½°ßòëƒ…Lø}TÿüĞFIşğµ¡Y(ZM2Ñéáıááİ ¡Ã±/Lü0ÃĞ‡ƒııæÛvgBP!Ñ[ôh›è<“v¹%ò•ñ/ívƒ|"9):Ş9+$Ç‰¤Å©%ÎÛ5.ÒvÉ@-o7%g/4½í9É°¤¬-!%%æRİÔ‘^©<wÊ*ùÌª"}û/:üÖ÷Î¶4÷œeµ
GyÆÚUyÆ<Ç	%İîV!)I‡28M97¢ã2Ë^H»¥BT7ÅŒ·«„,;.üŠ9)z
ÙñfÁk'“QãvTgD×©æ:\ÌÉ©‚È2~å×Šò:ybr~÷ÁA–9qµ
qƒ‰ØaxŞUÑ|-·möëåV³C´ÛÆ(Ş/çÑlÅ‡VİHµ©|„¦é4ª6„Ó”â­Î Ÿûš'3qmå‡ãÄ‘ÆZÓ1ÁT{Èû¨ó†Ó0şW¯eZ`„âõ‡Ì"9£Ò@›H›`0O¡˜n<XÓ¹g±MÓ4ôˆ`>šşPÄvïEÔó]
‰Ÿ3*ÎÍ+ôı‰ëº^W¢İ>Ç´ğ§ó	pH#=W‚¶ÅÙ»gz¦åıIû8;ÂŠ‰’Jœ]+·#ïÏAU }ê‰³ªÔ8uÛgEB³óË0&NÓÓÜĞ¿¥m/m¡÷™½©Æ¬"¸!¤niJ•?ÊUõrxv¹'·~Ş(y×û0â?’hj%4G¡16ŞÇªHT˜q6¾§d+7‡6Òâv¾>·;Zıg`r·aÔ ÷Q»¦¬îÇ”¤ï¤i•·='/ôÚÉn4¸âÄ€¸	?2èÇEBŒû“DÃ—î Jzé	¸&ÑBNÏŠ®9ß™ñœ‘\LîÉËBTœhn5-w”ĞÔ‚ÒZ+
-ùF’J’4	Y®¶èTA|3õ²†¥i[ŞHiş©ğ·.»:ıã&Z(aB¾{9R‰ 
3xZp3øŸIx· š—`hK&ÀšäŒ‹Óèıv¨İDÃw'SøéÕQGiª¨Ûw…ÑQ4†„åe@ö‰Í»êö*V½mo^èhP.UıBnÕ©×…ú$’VIİÁîíS£DŸ"YI¡ÛGu¤‚Mm-djxºZf À­—ñ:5Dß¿‚e–]£¿ø<¯¡ö§hm‡>ÀµcZLƒµÜŠÎ(NÎŒehAËŒåøÇ íØ¦víìim?v[/·Ñî	­¢+¯v»õÜ¹¶†v0¢g€©® Ğå…Ş»ªQ›¶gş’vÏ[x²Ç
ùĞW–Ívdv²5ÀC¶Aâß£õ:2†®ÕxjšŸíOLK™ì¹#†î¢cC@,5y#ì¸J©j“šÓÜŞØ¿r‡:jîcŸïú°æıŒ æ5wê+‡ÇØ—ûh®§Õ²ÿ•Á/ÅÈ²Ô¼à_‡×‘¾%$dkj{z¶‹H½¼ÙEÛ»§Mïö§^_`HCFªßğLÎ‡¿´æKÕåê—›‘’©“¤4<ÓÀ&Æ@Ñ|a™ZÍ÷sÎ¯#T=á ¢&Ä¸u®©?—–½Ç‚ ø"$ÉÑgXîÀ˜ úı.¤’…>AŸ£ò‚0|ñpßCİ–şdö0´Õş05á¾R6$¥ğ†Á:ôƒ:Mƒ,mhÂ™`G‰vÇ#U³€e
¦©,(.á{+g˜í´«dÆØhfûÙµ4f°êsÚ¡m'´o†:ÕÚ‹Q+]½“|.Ôˆ&¡ùôFŸsôDJÆ%à4¤š•jx*òôâİI“*c ‰” £pæ@{L3ÔNÜó0N}¤+ÀOåvËIñiò¿<<|‚ßïLÿ`
endstream
endobj
14 0 obj
<<
/F1 18 0 R
/F3 19 0 R
>>
endobj
15 0 obj
<<
/N 3
/Length 20 0 R
/Filter /FlateDecode
>>
stream
xœ–wXSçÇßsNö`$!l{†¥@ ‘¦€Ù¢’  $÷@T°¢¨ÈR)ŠX°Z†Ô‰(ŠâŞR”Z¬âÂÑD§õööŞÛÛïç|ßûû½çı÷y ¤€L®0V@(’ˆ#ü½±qñì €`€= nn¶WXX0+Ğ—ÍÈ•;Ñ«› R¼¯1{ÿOªÜl± (LÎ³xü\®œ‹äœ™/ÉVØ'åLKÎP0ŒR°X~@9k(8u†­?ûÌ°§‚yBOÎ‘rÎæ	y
î•ó†<)_Îˆ"—â<?_Î×ålœ)
äüF+äsä9 H
»„ÏM“³œIâÈ¶œç €#¥~ÁÉ_°„_ Q$ÅÎÊ.RÓ$s®ÃŞÅ…Åàçgò%f‡›Áóì,a6GTÀLÎŸEQÔ–!/²“½‹“ÓÁÆş‹Bı×Å¿)EogèEøçAôş?lå—Õ  kJ^›-Ø’« è\€Æİ?lÆ{ P–÷­ãòùĞó’&‘d»ÚÚæççÛø\EA×ÿtøúâ{6Ší~/Ã‡ŸÂ‘fJŠºq³2³¤bFn6‡Ëg0ÿ<Äÿ8ğ¯ÏaÁOá‹ù"yD´|Ê¢Ty»E<D%bDÿ©‰ÿ0ìOš™k¹¨-Ñ¨\¦äç~€¢’°[¾ıŞ·`|4PÜ¼ıÑ™¹ÿ,èßw…Ë\Aêç8vD$ƒ+çÍ¬)®%@P4 	ô€0Là œğ¾`‘ ,\„@òÁ2°ƒR°ì Õ 4‚fĞ
ƒNpœçÀ%pÜ ÷€Œ€§`¼Óa!2D…4!}È²‚ 4ò…‚¡(J‚R!$…–Ak¡R¨ª†ê¡fè[è(tº Bw !húz#0	¦Áº°)l³`/8„Á©p¼.‚7Ã•p|î€OÃ—à°~
O! !"tÄ a",„„"ñH
"FV %HÒ€´"İHr‘!È[EE1PL”* …â¢rP+P›PÕ¨ı¨T/êj5‰úˆ&£uĞVhWt :ŠÎG£+ĞMèvôYôôúƒ¡cÌ0Î˜ L&³³	³Ó†9…Äc¦°X¬&Ö
ëÅr°l1¶
{{{;‚}ƒ#âôq8?\<N„[ƒ«ÀÀÀ]Åâ¦ñ*x¼+>ÏÃâËğønüeü~š J0#¸"	é„Õ„JB+á,á>á‘H4$ºÃ‰â*b%ññ<qˆø–D!Y’Ø¤’”´™´tŠt‡ô‚L&›’=Éñd	y3¹™|†üüF‰ªd£¨ÄSZ©T£Ô¡tUé™2^ÙDÙKy±òå
å#Ê—•'Tğ*¦*lÊ
••£*·T¦T©ªöª¡ªBÕMªT/¨Q°SŠ/…G)¢ì¥œ¡Sª•MåR×R©g©#4ÍŒHK§•Ò¾¡Ğ&Õ(j³Õ¢Õ
ÔjÔ«Éèİ”HÏ¤—ÑÓoÒß©ëª{©óÕ7ª·ª_U­¡­á©Á×(ÑhÓ¸¡ñN“¡é«™¡¹U³SóJËR+\+_k·ÖY­	mš¶›6W»Dû°ö]XÇR'Bg©Î^~)]=]İlİ*İ3ºzt=O½t½íz'ôÆõ©úsõúÛõOê?a¨1¼™ŒJF/cÒ@Ç À@jPo0`0mhfe¸Æ°ÍğÁˆe”b´İ¨ÇhÒXß8Äx™q‹ñ]¼	Ë$Íd§IŸÉkS3ÓÓõ¦¦cfffKÌZÌî›“Í=ÌsÌÌ¯[`,X»,®XÂ––i–5–—­`+'+Õ.«Ak´µ‹µÈºÁú“Äôbæ1[˜C6t›`›566Ïlmãm·ÚöÙ~´s´Ë´k´»gO±Ÿg¿Æ¾ÛşWK®CÃõYäY~³VÎêšõ|¶Õlşìİ³o;RC×;ö8~prv;µ:;;'9×:ßbÑXa¬M¬ó.ho—•.Ç\Şº:¹J\»şâÆtËp;à66ÇlNãœawCw{½»l.cnÒÜ=seGF<Ï&ÏQ/¯t¯ƒ^Ï¼í¼ÅŞíŞ¯Ù®ìåìS>ˆ¿O‰Ï€/Å7Ê·Ú÷¡Ÿ¡_ª_‹ß¤¿£ÿRÿSè€ €­·u¹Í“óœç-Ÿ×D
ZTô(Ø2XÜ‡ÌÙr¾É|ÑüÎPº-ôA˜YXNØ÷á˜ğ°ğšğÇöË"úP$.8°àU¤wdYä½(ó(iTO´rtBtsôëŸ˜òY¬mìòØKqZq‚¸®xl|t|SüÔBß…;$8&'Ü\d¶¨`Ñ…ÅZ‹3OTNä$IB'Å$HzÏ	å4p¦’“k“'¹lîNîS'o;oœïÎ/ç¦¸§”§Œ¥º§nKOóH«H›°Õ‚çééué¯3B3öe|ÊŒÉlâ„IÂ£"Š(CÔ›¥—U5˜m•]œ-ËqÍÙ‘3)7åB¹‹r»$4ùÏT¿Ô\ºN:”77¯&ïM~tş‘ÕQA¡eáÆÂÑ%~K¾^ŠZÊ]Ú³Ì`ÙêeCË½–×¯€V$¯èYi´²håÈ*ÿUûWVg¬şaİšò5/×Æ¬í.Ò-ZU4¼Î]K±R±¸øÖz·õuP6ÎÚXµñc	¯äb©]iEéûMÜM¿²ÿªò«O›S6”9•íŞ‚Ù"Úrs«ÇÖıåªåKÊ‡·…lëØÎØ^²ıåÄ*fWÔí$ì”î”UWvUWm©z_V}£Æ»¦­V§vcíë]¼]Ww{în­Ó­+­{·G°çv½}GƒiCÅ^ÌŞ¼½£û¾f}İÜ¤ÕTÚôaŸhŸlÄşŞfçææ:ÊZàiËøÁ„ƒW¾ñù¦«•ÙZßFo+=I=ù6éÛ›‡ƒ÷aiıÎä»Úvj{IÔQØ1Ù™Ö)ëŠë<:ïhO·[wû÷6ßï;fp¬æ¸Úñ²„E'>\rrêTö©‰Ó©§‡{{î‰=s½7¼wàlĞÙóçüÎéóê;yŞıü±®^d]ì¼ät©£ß±¿ıÇÚœ:.;_îºâr¥{pÎà‰«WO_ó¹vîzàõK7æß¼uóö­„[²Û¼Ûcw2ï<¿›wwúŞªûèû%TT<ÔyØğ£Åm2'Ùñ!Ÿ¡şGİæ?ı)÷§÷#EÉ+FõG›ÇÆû_y²ğÉÈÓì§ÓÅ?«ş\ûÌüÙw¿xşÒ?;9ò\üüÓ¯›^h¾Ø÷röË©°©‡¯„¯¦_—¼Ñ|³ÿ-ëmß»˜w£Óùï±ï+?X|èşôñş'á§O¿Éâôâ
endstream
endobj
16 0 obj
6300
endobj
17 0 obj
1484
endobj
18 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
>>
endobj
19 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica-Bold
/Encoding /WinAnsiEncoding
>>
endobj
20 0 obj
2592
endobj
xref
0 21
0000000000 65535 f
0000000015 00000 n
0000000299 00000 n
0000000362 00000 n
0000001377 00000 n
0000000112 00000 n
0000001423 00000 n
0000001599 00000 n
0000001775 00000 n
0000001794 00000 n
0000001822 00000 n
0000001851 00000 n
0000001973 00000 n
0000008330 00000 n
0000009892 00000 n
0000009936 00000 n
0000012611 00000 n
0000012632 00000 n
0000012653 00000 n
0000012751 00000 n
0000012854 00000 n
trailer
<<
/Size 21
/Root 1 0 R
/Info 5 0 R
/ID [<1D20CA1D321FA1037ADEE7FF7F5A7481> <1D20CA1D321FA1037ADEE7FF7F5A7481>]
>>
startxref
12875
%%EOF
